Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Linke

Showing results (421-430 of 444) with videos related to

Pageof 45
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2026
Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trialMiklos Rohla, Kurt Huber, Ferdinando Varbella, et al.
European Journal of Heart Failure|November 8, 2023
Clinical presentation, shock severity and mortality in patients with de novo versus acute-on-chronic heart failure-related cardiogenic shockJonas Sundermeyer, Caroline Kellner, Benedikt N Beer, et al.
The New England Journal of Medicine|August 27, 2023
Timing of Complete Revascularization with Multivessel PCI for Myocardial InfarctionBarbara E Stähli, Ferdinando Varbella, Axel Linke, et al.
Scientific Reports|June 26, 2026
Killip class at presentation and immediate versus staged multivessel PCI in patients with STEMIPhilipp Jakob, Ferdinando Varbella, Axel Linke, et al.
Journal of the American College of Cardiology|December 12, 2025
1-Year Outcomes of Novel Balloon-Expandable vs Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis: The LANDMARK TrialPatrick W Serruys, Akihiro Tobe, Niels van Royen, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 14, 2024
Sex-related differences in patients presenting with heart failure-related cardiogenic shockJonas Sundermeyer, Caroline Kellner, Benedikt N Beer, et al.
European Heart Journal. Cardiovascular Imaging|August 28, 2025
Comparative 30-day Echocardiographic Outcomes of Myval versus Sapien and Evolut THVs: Insights from LANDMARK TrialOsama Soliman, Elfatih A Hasabo, Niels van Royen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2024
Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals with severe aortic stenosisNiels van Royen, Ignacio J Amat-Santos, Martin Hudec, et al.
International Journal of Cardiology. Heart & Vasculature|October 13, 2025
Quantitative videodensitometric assessment of aortic regurgitation in Myval, Sapien, and Evolut THV series: Results from the LANDMARK trialElfatih A Hasabo, Niels van Royen, Ignacio J Amat-Santos, et al.
International Journal of Cardiology|April 27, 2026
Pacemaker recovery after permanent pacemaker implantation post-transcatheter aortic valve implantation: A sub-study of the LANDMARK trialAkihiro Tobe, Pieter C Smits, Niels van Royen, et al.
Pageof 45

Showing results (421-430 of 444) with videos related to

Sort By:
Pageof 45
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2026
Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trialMiklos Rohla, Kurt Huber, Ferdinando Varbella, et al.
European Journal of Heart Failure|November 8, 2023
Clinical presentation, shock severity and mortality in patients with de novo versus acute-on-chronic heart failure-related cardiogenic shockJonas Sundermeyer, Caroline Kellner, Benedikt N Beer, et al.
The New England Journal of Medicine|August 27, 2023
Timing of Complete Revascularization with Multivessel PCI for Myocardial InfarctionBarbara E Stähli, Ferdinando Varbella, Axel Linke, et al.
Scientific Reports|June 26, 2026
Killip class at presentation and immediate versus staged multivessel PCI in patients with STEMIPhilipp Jakob, Ferdinando Varbella, Axel Linke, et al.
Journal of the American College of Cardiology|December 12, 2025
1-Year Outcomes of Novel Balloon-Expandable vs Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis: The LANDMARK TrialPatrick W Serruys, Akihiro Tobe, Niels van Royen, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 14, 2024
Sex-related differences in patients presenting with heart failure-related cardiogenic shockJonas Sundermeyer, Caroline Kellner, Benedikt N Beer, et al.
European Heart Journal. Cardiovascular Imaging|August 28, 2025
Comparative 30-day Echocardiographic Outcomes of Myval versus Sapien and Evolut THVs: Insights from LANDMARK TrialOsama Soliman, Elfatih A Hasabo, Niels van Royen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2024
Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals with severe aortic stenosisNiels van Royen, Ignacio J Amat-Santos, Martin Hudec, et al.
International Journal of Cardiology. Heart & Vasculature|October 13, 2025
Quantitative videodensitometric assessment of aortic regurgitation in Myval, Sapien, and Evolut THV series: Results from the LANDMARK trialElfatih A Hasabo, Niels van Royen, Ignacio J Amat-Santos, et al.
International Journal of Cardiology|April 27, 2026
Pacemaker recovery after permanent pacemaker implantation post-transcatheter aortic valve implantation: A sub-study of the LANDMARK trialAkihiro Tobe, Pieter C Smits, Niels van Royen, et al.
Pageof 45